Ketamine as an adjunctive therapy for major depression - a randomised controlled pragmatic pilot trial (Karma-Dep Trial)

Background: Depression is a common psychiatric disorder that has become the leading cause of disability worldwide. The standard medical care for depression over the past 50 years has focused on monoamine neurotransmitters. These treatments can take weeks to take effect, highlighting the need for nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallagher, Bronagh, Foley, Meabh, Slattery, Claire M., Gusciute, Gabriele, Shanahan, Enda, McLoughlin, Declan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729188/
https://www.ncbi.nlm.nih.gov/pubmed/35036831
http://dx.doi.org/10.12688/hrbopenres.13182.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729188/
https://www.ncbi.nlm.nih.gov/pubmed/35036831
http://dx.doi.org/10.12688/hrbopenres.13182.2

Ejemplares similares